Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha therapy in atopic dermatitis.

A Torrelo1, A Harto, E Sendagorta

  • 1Department of Dermatology, Hospital Ramón y Cajal, Madrid, Spain.

Acta Dermato-Venereologica
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.

Pediatric dermatology·2024
Same author

First update of the living European guideline (EuroGuiDerm) on atopic eczema.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Clinical Unmet Needs and Treatment Patterns of Paediatric Psoriasis Patients: A Real-World Evidence Study in Spain.

Actas dermo-sifiliograficas·2023
Same author

Clinical Unmet Needs and Treatment Patterns of Paediatric Psoriasis Patients: A Real-World Evidence Study in Spain.

Actas dermo-sifiliograficas·2023
Same journal

A Facial Lesion with Cord-like Induration and Ring-like Appearance on MRI: A Quiz.

Acta dermato-venereologica·2026
Same journal

Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study.

Acta dermato-venereologica·2026
Same journal

An 8-year-old Girl with Multiple Whitish Dots on the Hair Shaft: A Quiz.

Acta dermato-venereologica·2026
Same journal

A Congenital Subcutaneous Tumour of the Scalp in a Child: A Quiz.

Acta dermato-venereologica·2026
Same journal

Commentary on: "The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma".

Acta dermato-venereologica·2026
Same journal

Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study.

Acta dermato-venereologica·2026
See all related articles

Recombinant interferon-alpha 2a (rIFN-alpha 2a) showed moderate benefits for severe adult atopic dermatitis (AD). While not affecting IgE levels, it offered therapeutic potential for immune deficiencies in AD patients.

Area of Science:

  • Immunology
  • Dermatology
  • Virology

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin condition.
  • Severe adult AD presents significant therapeutic challenges.
  • Immunologic dysregulation is implicated in AD pathogenesis.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of recombinant interferon-alpha 2a (rIFN-alpha 2a) in patients with severe adult atopic dermatitis.
  • To assess the impact of rIFN-alpha 2a on serum IgE levels and adverse effects.

Main Methods:

  • Thirteen patients with severe adult AD were treated with rIFN-alpha 2a (3.0 x 10^6 IU) three times weekly.
  • Clinical response, serum IgE levels, and adverse events were monitored.

Main Results:

Related Experiment Videos

  • A satisfactory therapeutic response was observed in 5 out of 13 patients.
  • Serum IgE levels remained unchanged in all patients throughout the study.
  • Flu-like symptoms were common; other clinical or laboratory adverse effects were minimal.

Conclusions:

  • rIFN-alpha 2a demonstrated moderately beneficial therapeutic effects in severe adult atopic dermatitis.
  • These findings suggest a potential role for interferon-alpha in managing immunologic deficiencies associated with AD.
  • Further research is warranted to explore the immunomodulatory mechanisms of IFN-alpha in AD.